Multidimensional treatment of periprosthetic joint infection using fusion peptide-grafted chitosan coated porous tantalum scaffold

Bacterial infection and delayed osteointegration are two major challenges for orthopedic implants. Surface modification enables the implant have a time-sequenced biological function of effective antibacterial in the early stage and stable osteogenesis in the later stage, which is expected to achieve the purpose of preventing infection and prosthetic loosening after implant surgery. This study aims to construct a composite coating of carboxymethyl chitosan (CCS) grafted with an antibacterial (HHC36) and angiogenic (FP) fusion peptide (FP) on the surface of 3D-printed porous tantalum (Ta-CCS@FP) using alkaline treatment, electrostatic adsorption, and EDC/NHS reaction, to functionalize the surface coating while maintaining the original advantages of the material. The functionalized implants (Ta-CCS@FP) achieve sustained FP release in the initial stages, exhibiting potent antibacterial and anti-biofilm properties due to the synergistic action of the antimicrobial peptides (AMPs) HHC36 and CCS in disrupting bacterial membranes. Additionally, Ta-CCS@FP demonstrate robust osteogenic and angiogenic capabilities compared to Ta and Ta-CCS, attributed to QK and CCS. Notably, the conditioned medium intervention experiments of HUVECs and BMSCs showed that the implants had good angiogenic-osteogenic coupling properties. In vivo assays using infection bone defect models revealed that these bioactive implants effectively eradicated bacteria within 2 weeks and facilitated vascularized bone regeneration by 6 weeks. Thus, our study offers an integrated approach to address bacterial infection and enhance osseointegration for porous tantalum implants. • Developed an economical and highly feasible composite coating technology for 3D-printed porous tantalum. • The coated porous tantalum scaffold possesses synergistic antibacterial properties along with promoting osseointegration abilities. • The coated porous tantalum scaffold is a promising bone substitute for infection-related bone defects.

Authors

Institutions

Publication Details

Journal
Bioactive Materials
Published
2024-10-11
DOI
https://doi.org/10.1016/j.bioactmat.2024.09.040
Citations
9
Primary Topic
Orthopaedic implants and arthroplasty
Type
article
Field-Weighted Citation Impact
5.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multidimensional treatment of periprosthetic joint infection using fusion peptide-grafted chitosan coated porous tantalum scaffold

Zixuan Xiong, Zhenyang Xiao, Yihe Hu, Kai Zhang et al.
9 citations
Bioactive Materials
Orthopaedic implants and arthroplasty
5.15
article

Multidimensional treatment of periprosthetic joint infection using fusion peptide-grafted chitosan coated porous tantalum scaffold

Zixuan Xiong, Zhenyang Xiao, Yihe Hu, Kai Zhang, Wenbin Liu, Yan Sun, Hongkun Hu
article en
9 citations

Abstract

Bacterial infection and delayed osteointegration are two major challenges for orthopedic implants. Surface modification enables the implant have a time-sequenced biological function of effective antibacterial in the early stage and stable osteogenesis in the later stage, which is expected to achieve the purpose of preventing infection and prosthetic loosening after implant surgery. This study aims to construct a composite coating of carboxymethyl chitosan (CCS) grafted with an antibacterial (HHC36) and angiogenic (FP) fusion peptide (FP) on the surface of 3D-printed porous tantalum (Ta-CCS@FP) using alkaline treatment, electrostatic adsorption, and EDC/NHS reaction, to functionalize the surface coating while maintaining the original advantages of the material. The functionalized implants (Ta-CCS@FP) achieve sustained FP release in the initial stages, exhibiting potent antibacterial and anti-biofilm properties due to the synergistic action of the antimicrobial peptides (AMPs) HHC36 and CCS in disrupting bacterial membranes. Additionally, Ta-CCS@FP demonstrate robust osteogenic and angiogenic capabilities compared to Ta and Ta-CCS, attributed to QK and CCS. Notably, the conditioned medium intervention experiments of HUVECs and BMSCs showed that the implants had good angiogenic-osteogenic coupling properties. In vivo assays using infection bone defect models revealed that these bioactive implants effectively eradicated bacteria within 2 weeks and facilitated vascularized bone regeneration by 6 weeks. Thus, our study offers an integrated approach to address bacterial infection and enhance osseointegration for porous tantalum implants. • Developed an economical and highly feasible composite coating technology for 3D-printed porous tantalum. • The coated porous tantalum scaffold possesses synergistic antibacterial properties along with promoting osseointegration abilities. • The coated porous tantalum scaffold is a promising bone substitute for infection-related bone defects.

Bioactive MaterialsVol. 44
Central South University (CN), Third Xiangya Hospital (CN), Xiangya Hospital Central South University (CN), Hunan Provincial Maternal and Child Health Hospital (CN), Zhejiang University (CN), University of South China (CN)
Health Commission of Hunan Province, National Natural Science Foundation of China, Hunan Association for Science and Technology, Key Technologies Research and Development Program
Openalex Percentile: Top 4%
Orthopaedic implants and arthroplasty
5.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.